Literature DB >> 28276080

Combining biomarkers for classification with covariate adjustment.

Soyoung Kim1, Ying Huang2.   

Abstract

Combining multiple markers can improve classification accuracy compared with using a single marker. In practice, covariates associated with markers or disease outcome can affect the performance of a biomarker or biomarker combination in the population. The covariate-adjusted receiver operating characteristic (ROC) curve has been proposed as a tool to tease out the covariate effect in the evaluation of a single marker; this curve characterizes the classification accuracy solely because of the marker of interest. However, research on the effect of covariates on the performance of marker combinations and on how to adjust for the covariate effect when combining markers is still lacking. In this article, we examine the effect of covariates on classification performance of linear marker combinations and propose to adjust for covariates in combining markers by maximizing the nonparametric estimate of the area under the covariate-adjusted ROC curve. The proposed method provides a way to estimate the best linear biomarker combination that is robust to risk model assumptions underlying alternative regression-model-based methods. The proposed estimator is shown to be consistent and asymptotically normally distributed. We conduct simulations to evaluate the performance of our estimator in cohort and case/control designs and compare several different weighting strategies during estimation with respect to efficiency. Our estimator is also compared with alternative regression-model-based estimators or estimators that maximize the empirical area under the ROC curve, with respect to bias and efficiency. We apply the proposed method to a biomarker study from an human immunodeficiency virus vaccine trial.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  area under the ROC curve; biomarker combination; classification; covariate adjustment; receiver operating characteristic curve

Mesh:

Substances:

Year:  2017        PMID: 28276080      PMCID: PMC5459674          DOI: 10.1002/sim.7274

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

Review 2.  The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2003-04-02       Impact factor: 13.506

3.  Combining several screening tests: optimality of the risk score.

Authors:  Martin W McIntosh; Margaret Sullivan Pepe
Journal:  Biometrics       Date:  2002-09       Impact factor: 2.571

4.  Combining multiple markers for classification using ROC.

Authors:  Shuangge Ma; Jian Huang
Journal:  Biometrics       Date:  2007-09       Impact factor: 2.571

5.  Semiparametric estimation of the covariate-specific ROC curve in presence of ignorable verification bias.

Authors:  Danping Liu; Xiao-Hua Zhou
Journal:  Biometrics       Date:  2011-03-01       Impact factor: 2.571

6.  Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve.

Authors:  Holly Janes; Margaret S Pepe
Journal:  Biometrika       Date:  2009-04-01       Impact factor: 2.445

7.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

Authors:  Barton F Haynes; Peter B Gilbert; M Juliana McElrath; Susan Zolla-Pazner; Georgia D Tomaras; S Munir Alam; David T Evans; David C Montefiori; Chitraporn Karnasuta; Ruengpueng Sutthent; Hua-Xin Liao; Anthony L DeVico; George K Lewis; Constance Williams; Abraham Pinter; Youyi Fong; Holly Janes; Allan DeCamp; Yunda Huang; Mangala Rao; Erik Billings; Nicos Karasavvas; Merlin L Robb; Viseth Ngauy; Mark S de Souza; Robert Paris; Guido Ferrari; Robert T Bailer; Kelly A Soderberg; Charla Andrews; Phillip W Berman; Nicole Frahm; Stephen C De Rosa; Michael D Alpert; Nicole L Yates; Xiaoying Shen; Richard A Koup; Punnee Pitisuttithum; Jaranit Kaewkungwal; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Nelson L Michael; Jerome H Kim
Journal:  N Engl J Med       Date:  2012-04-05       Impact factor: 91.245

8.  ROC analysis in biomarker combination with covariate adjustment.

Authors:  Danping Liu; Xiao-Hua Zhou
Journal:  Acad Radiol       Date:  2013-07       Impact factor: 3.173

9.  Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provide.

Authors:  Morgane Rolland; Peter Gilbert
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-27       Impact factor: 2.205

10.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

View more
  1 in total

1.  Application of latent class analysis in diagnosis of graft-versus-host disease by serum markers after allogeneic haematopoietic stem cell transplantation.

Authors:  Maedeh Amini; Anoshirvan Kazemnejad; Aliakbar Rasekhi; Farid Zayeri; Abbas Hajifathali; Farzaneh Tavakoli
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.